Meiogenix Announces $13 Million Series A Financing Round Led By Sofinnova Partners
Dec 14, 2021•over 3 years ago
Amount Raised
$13 Million
Round Type
series a
Description
Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (€11 million) Series A financing round, led by Sofinnova Partners, with participation from Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech